Frier Levitt was recently successful in reversing a New Jersey pharmacy’s network termination by a major PBM.  The PBM had sent Notices of Termination alleging that the pharmacy failed to comply with terms and conditions of the PBM Provider... Read More
Antitrust Tools Available to Combat PBM Abuse of Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Recent Results

The Section 340B federal discount drug program (340B program) is a federal program under which pharmaceutical manufacturers enter into contracts with the U.S. Department of Health & Human Services (HHS) in exchange for obtaining Medicaid and... Read More
340B Covered Entity and Contract Pharmacy Regulatory and Contract Support | Articles | Life Sciences | Pharmaceutical Manufacturers | Pharmacy Law | Pharmacy Transactions | Section 340B In-House and Contract Pharmacies

As independent pharmacies across the country look for ways to diversify and grow the scope of products available to their patients, many consider expanding into the durable medical equipment (DME) space, such as wheelchairs, walkers, crutches, and... Read More
Articles | Community, Retail Pharmacies | Life Sciences | Long-Term Care Pharmacies | Pharmacy Law | Physician Dispensing | Specialty Pharmacies | Value Based Care

Direct and indirect remuneration (DIR) fees paid by pharmacy providers to pharmacy benefit managers (PBMs) are on the rise for the upcoming calendar year in 2022.  Pharmacy DIR fees have been utilized by PBMs to recoup monies on claims submissions... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Digital Pharmacies | DIR Fees | Life Sciences | Pharmacy Law | Pharmacy Transactions

Effective on January 1, 2022, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) will implement the Final Rule for Medicare and Medicaid Programs. The Final Rule establishes pharmacy... Read More
Articles | Chain Pharmacies | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Pharmacy Transactions | Plan Sponsor PBM Contract Services

Under the Section 340B federal discount drug program (340B program), pharmaceutical manufacturers enter into contracts with the Health & Human Services (HHS) in exchange for having their drugs covered by Medicaid and Medicare.  Pursuant to... Read More
Articles | Life Sciences | Manufacturers | Pharmacy Law | Section 340B In-House and Contract Pharmacies

Frier Levitt successfully reversed a five year wait for readmission for an independent pharmacy into one of the largest Pharmacy Benefit Managers (“PBM”) pharmacy networks.  More specifically, the pharmacy was terminated by the PBM in 2017 for... Read More
Articles | Defending Pharmacies in PBM Audits | Life Sciences | Payor Network Access and Defense of Network Terminations | Pharmacy Law | Recent Results | Specialty Pharmacies